Dr Lynn Drummond has had a distinguished career in the pharmaceutical and life sciences sectors, spending 16 years as a Managing Director within Investment Banking for Rothschild. Prior to Rothschild, Lynn worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor.
Dr Drummond is currently Chair of the Board of Governors at the University of Hertfordshire; a non-Executive Director and Chair designate at Zotefoams plc and also works as a Board Mentor for Criticaleye. She has held additional Non-Executive Directorships at Venture Life Group plc; RPC Group plc; Infirst Healthcare; Shield Holdings AG; Allocate Software plc; Consort Medical plc; and Alimentary Health Ireland. Lynn has also been Chairman of Trustees for Breast Cancer Haven, and was on the University of Cambridge, Centre for Science and Policy Development Group.
Lynn holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is a Fellow of the Royal Society of Chemistry, and a Fellow of the Royal Society of Edinburgh.